Royal Bank of Canada’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $140M | Buy |
430,835
+93,604
| +28% | +$30.5M | 0.03% | 466 |
|
|
2025
Q1 | $91.1M | Buy |
337,231
+27,044
| +9% | +$7.3M | 0.02% | 541 |
|
|
2024
Q4 | $73M | Sell |
310,187
-100,879
| -25% | -$23.7M | 0.01% | 622 |
|
|
2024
Q3 | $113M | Sell |
411,066
-298
| -0.1% | -$82K | 0.02% | 478 |
|
|
2024
Q2 | $100M | Buy |
411,364
+36,940
| +10% | +$8.98M | 0.02% | 479 |
|
|
2024
Q1 | $56M | Buy |
374,424
+116,469
| +45% | +$17.4M | 0.01% | 671 |
|
|
2023
Q4 | $49.4M | Buy |
257,955
+13,849
| +6% | +$2.65M | 0.01% | 702 |
|
|
2023
Q3 | $43.2M | Sell |
244,106
-2,116
| -0.9% | -$375K | 0.01% | 683 |
|
|
2023
Q2 | $46.8M | Buy |
246,222
+30,063
| +14% | +$5.71M | 0.01% | 666 |
|
|
2023
Q1 | $43.3M | Buy |
216,159
+19,579
| +10% | +$3.92M | 0.01% | 670 |
|
|
2022
Q4 | $46.7M | Buy |
196,580
+130,564
| +198% | +$31M | 0.01% | 647 |
|
|
2022
Q3 | $13.2M | Sell |
66,016
-15,087
| -19% | -$3.02M | ﹤0.01% | 1180 |
|
|
2022
Q2 | $11.8M | Buy |
81,103
+58,508
| +259% | +$8.53M | ﹤0.01% | 1280 |
|
|
2022
Q1 | $3.69M | Sell |
22,595
-5,606
| -20% | -$916K | ﹤0.01% | 2181 |
|
|
2021
Q4 | $4.78M | Buy |
28,201
+3,609
| +15% | +$612K | ﹤0.01% | 2053 |
|
|
2021
Q3 | $4.64M | Buy |
24,592
+8,464
| +52% | +$1.6M | ﹤0.01% | 2038 |
|
|
2021
Q2 | $2.73M | Sell |
16,128
-71
| -0.4% | -$12K | ﹤0.01% | 2459 |
|
|
2021
Q1 | $2.29M | Sell |
16,199
-13,326
| -45% | -$1.88M | ﹤0.01% | 2529 |
|
|
2020
Q4 | $3.84M | Buy |
29,525
+9,962
| +51% | +$1.29M | ﹤0.01% | 2052 |
|
|
2020
Q3 | $2.85M | Sell |
19,563
-4,205
| -18% | -$612K | ﹤0.01% | 2080 |
|
|
2020
Q2 | $3.52M | Buy |
23,768
+857
| +4% | +$127K | ﹤0.01% | 1918 |
|
|
2020
Q1 | $2.49M | Buy |
22,911
+2,579
| +13% | +$281K | ﹤0.01% | 1999 |
|
|
2019
Q4 | $2.34M | Sell |
20,332
-15,782
| -44% | -$1.82M | ﹤0.01% | 2302 |
|
|
2019
Q3 | $2.9M | Sell |
36,114
-4,110
| -10% | -$330K | ﹤0.01% | 2065 |
|
|
2019
Q2 | $2.92M | Buy |
40,224
+26,538
| +194% | +$1.93M | ﹤0.01% | 2084 |
|
|
2019
Q1 | $1.28M | Buy |
13,686
+2,223
| +19% | +$208K | ﹤0.01% | 2550 |
|
|
2018
Q4 | $835K | Buy |
11,463
+1,318
| +13% | +$96K | ﹤0.01% | 2782 |
|
|
2018
Q3 | $888K | Buy |
10,145
+3,014
| +42% | +$264K | ﹤0.01% | 2933 |
|
|
2018
Q2 | $703K | Buy |
7,131
+1,666
| +30% | +$164K | ﹤0.01% | 2986 |
|
|
2018
Q1 | $651K | Buy |
5,465
+2,778
| +103% | +$331K | ﹤0.01% | 2959 |
|
|
2017
Q4 | $341K | Buy |
2,687
+924
| +52% | +$117K | ﹤0.01% | 3392 |
|
|
2017
Q3 | $207K | Buy |
1,763
+280
| +19% | +$32.9K | ﹤0.01% | 3793 |
|
|
2017
Q2 | $118K | Sell |
1,483
-3,877
| -72% | -$308K | ﹤0.01% | 3970 |
|
|
2017
Q1 | $274K | Buy |
5,360
+1,951
| +57% | +$99.7K | ﹤0.01% | 3524 |
|
|
2016
Q4 | $128K | Sell |
3,409
-54,271
| -94% | -$2.04M | ﹤0.01% | 4010 |
|
|
2016
Q3 | $3.91M | Buy |
57,680
+6,366
| +12% | +$432K | ﹤0.01% | 1664 |
|
|
2016
Q2 | $2.85M | Buy |
51,314
+19,827
| +63% | +$1.1M | ﹤0.01% | 1826 |
|
|
2016
Q1 | $1.98M | Buy |
31,487
+5,382
| +21% | +$338K | ﹤0.01% | 2049 |
|
|
2015
Q4 | $2.46M | Buy |
26,105
+13,884
| +114% | +$1.31M | ﹤0.01% | 1919 |
|
|
2015
Q3 | $982K | Sell |
12,221
-455
| -4% | -$36.6K | ﹤0.01% | 2395 |
|
|
2015
Q2 | $1.52M | Sell |
12,676
-4,777
| -27% | -$572K | ﹤0.01% | 2180 |
|
|
2015
Q1 | $1.82M | Buy |
17,453
+9,619
| +123% | +$1M | ﹤0.01% | 2001 |
|
|
2014
Q4 | $759K | Sell |
7,834
-16,330
| -68% | -$1.58M | ﹤0.01% | 2667 |
|
|
2014
Q3 | $1.89M | Buy |
24,164
+16,401
| +211% | +$1.28M | ﹤0.01% | 1963 |
|
|
2014
Q2 | $490K | Buy |
7,763
+6,507
| +518% | +$411K | ﹤0.01% | 2966 |
|
|
2014
Q1 | $84K | Sell |
1,256
-2,053
| -62% | -$137K | ﹤0.01% | 4121 |
|
|
2013
Q4 | $214K | Sell |
3,309
-1,910
| -37% | -$124K | ﹤0.01% | 3518 |
|
|
2013
Q3 | $334K | Buy |
5,219
+1,694
| +48% | +$108K | ﹤0.01% | 3198 |
|
|
2013
Q2 | $109K | Buy |
+3,525
| New | +$109K | ﹤0.01% | 3693 |
|